Pleuroparenchymal fibroelastosis: role of high-resolution computed tomography (HRCT) and CT-guided transthoracic core lung biopsy

被引:22
作者
Esteves C. [1 ]
Costa F.R. [1 ]
Redondo M.T. [2 ]
Moura C.S. [3 ,4 ]
Guimarães S. [3 ]
Morais A. [2 ,4 ]
Pereira J.M. [1 ,4 ]
机构
[1] Department of Radiology, Centro Hospitalar de São João, Alameda Professor Hernâni Monteiro, Porto
[2] Department of Pneumology, Centro Hospitalar de São João, Alameda Professor Hernâni Monteiro, Porto
[3] Department of Pathology, Centro Hospitalar de São João, Alameda Professor Hernâni Monteiro, Porto
[4] University of Porto, Porto
关键词
Biopsy; Computed tomography; Fibrosis; Idiopathic interstitial pneumonia; Lung;
D O I
10.1007/s13244-015-0448-3
中图分类号
学科分类号
摘要
Objectives: Pleuroparenchymal fibroelastosis (PPFE) is a rare idiopathic interstitial pneumonia (IIP) with variable clinical and radiological features. Diagnosis is based on histology obtained by surgical lung biopsy, which is associated with significant mortality and morbidity. This study aims to briefly review PPFE and discuss the role of CT-guided transthoracic core lung biopsy (TTB) in its diagnosis. Materials/Methods: Four cases of PPFE diagnosed at our institution with TTB are reported and discussed. Results: Clinical, radiological and histological features are in agreement with the previous literature cases. TTB provided the diagnosis in all cases. Iatrogenic pneumothorax was the main complication in all patients. Placement of a chest tube was needed in three patients. An overlap between PPFE and other interstitial lung diseases (ILD) was documented. Conclusion: PPFE is an underdiagnosed IIP, so radiologist awareness of it needs to be widespread in patients with fibrosis with apical-caudal distribution. Coexistence of different lung diseases strengthens the idea of a predisposing factor. TTB proved to be a good diagnostic tool and can be considered the first choice for invasive assessment of these patients. PFFE has a variable course with no established therapeutic options; therefore a multidisciplinary team is crucial in the approach to patients with ILD. Main messages/Teaching Points: • PPFE should be considered in the differential diagnosis of fibrosis with apical-caudal distribution. • CT-guided TTB can be considered the first choice for invasive assessment of PPFE. • Site of biopsy has to be chosen carefully in order not to miss PPFE. • Coexistence of different lung diseases strengthens the idea of a predisposing factor. • A multidisciplinary team is crucial in the approach to patients with ILD. © 2015, The Author(s).
引用
收藏
页码:155 / 162
页数:7
相关论文
共 21 条
  • [1] Aminati R., Niimi A., Kuse F., Idiopathic pulmonar upper lobe fibrosis, Kokyu, 11, pp. 693-699, (1992)
  • [2] von der Thusen J.H., Pleuroparenchymal fibroelastosis: its pathological characteristics, Curr Respir Med Rev, 9, 4, pp. 238-247, (2014)
  • [3] Cuppens K., Verbeken E., Coolen J., Verschakelen J., Wuytsa W., Idiopathic pleuroparenchymatous fibroelastosis: a case report and brief review of the literature, Respir Med Case Rep, 12, pp. 7-9, (2014)
  • [4] Piciucchi S., Tomassetti S., Casoni G., Sverzellati N., Carloni A., Dubini A., Et al., High resolution CT and histological findings in idiopathic pleuroparenchymal fibroelastosis: features and differencial diagnosis, Respir Res, 12, (2011)
  • [5] Frankel S.K., Cool C.D., Lynch D.A., Brown K.K., Pleuroparenchymal fibroelastosis: description of a novel clinico-pathological entity, Chest, 126, pp. 2007-2013, (2004)
  • [6] von der Thusen J.H., Hansell D.M., Tominaga M., Veys P.A., Ashworth M.T., Owens C.M., Et al., Pleuroparenchymal fibroelastosis in patients with pulmonary disease secondary to bone marrow transplantation, Mod Pathol, 24, 12, pp. 1633-1639, (2011)
  • [7] Reddy T.L., Tominaga M., Hansell D.M., von der Thusen J., Rassl D., Parfrey H., Et al., Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes, Eur Resp J, 40, pp. 377-385, (2012)
  • [8] Hirota T., Fujita M., Matsumoto T., Higuchi T., Shiraishi T., Minami M., Et al., Pleuroparenchymal fibroelastosis as a manifestation of chronic lung rejection?, Eur Resp J, 41, pp. 243-245, (2013)
  • [9] Kusagaya H., Nakamura Y., Kono M., Kaida Y., Kuroishi S., Enomoto N., Idiopathic pleuroparenchymal fibroelastosis: consideration of a clinicopathological entity in a series of Japanese patients, BMC Pulm Med, pp. 12-72, (2012)
  • [10] Travis W.D., Costabel U., Hansell D.M., King T.E., Lynch D.A., Nicholson A.G., Et al., An Official American Thoracic Society/European Respiratory Society Statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias, Am J Respir Crit Care Med, 188, 6, pp. 733-748, (2013)